Cellebrite reports mixed Q2 2025 results: revenue slightly misses estimates at $113.3M, while EPS beats at $0.12. New CEO appointed amid leadership changes and strategic acquisitions. Stock dips pre-market.
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers during the week and a look at what could be causing the increased interest.
Earnings news has catalyzed frenzied activity in these stocks, and irrespective of the directional moves, sentiment toward them has remained uniformly upbeat.
In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.
Despite having a license for Cellebrite's software, the FBI's Pittsburgh bureau was unable to bypass the passcode on Crooks' newer Samsung model phone, which runs on Android's operating system.
Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and $370M-$380M for FY24.
